Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease

Key Points

• Thrombo-inflammation significantly impacts the clinical course of Kawasaki disease and its vascular complications.
• Aspirin administration is linked to improved inflammatory markers in affected individuals, with a noted decrease in severe outcomes.
• Observational analysis across various cases emphasizes the need to rethink treatment approaches, particularly involving aspirin.
• This suggests that evolving treatment strategies are essential for enhancing outcomes in Kawasaki disease and minimizing vascular risks.